glp 1 drugs fsa eligible TrimRX gymnema sylvestre extract Weight Loss by Patiently |
Description
Patients prescribed GLP-1 medications for diabetes or weight management have reported unexpected reductions in their desire to consume alcohol, with some describing a complete loss of interest in drinking

3 (8), a003947 (2011)

however, continuous use of GLP1 receptor agonists versus DPP4 inhibitors was associated with dementia risk reduction

Government records from the United States (US) suggest that the condition affects ~29 million Americans of the ~133 million alcohol consumers within the country
Wegovy: May be covered to reduce cardiovascular risk in adults with heart disease who are overweight or obese, and for the liver condition MASH

For more information, contact: